S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?
S&P 500   4,569.78
DOW   36,204.44
QQQ   386.32
Are penny stocks worth it? Should you invest in penny stocks?
All the trading advice you’ve ever received boils down to this (Ad)
Why do tech stocks go down when interest rates rise?
Pure Storage stock fumbles for a rare buying opportunity
All the trading advice you’ve ever received boils down to this (Ad)
Snowflake’s bullish tailwind is turning into a gale-force wind
2 energy drink makers to wake up your portfolio
All the trading advice you’ve ever received boils down to this (Ad)
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
Bitcoin has surpassed $41,000 for the first time since April 2022. What's behind the price surge?

Medifast Stock Price, News & Analysis (NYSE:MED)

$69.72
+1.41 (+2.06%)
(As of 12/4/2023 ET)
Compare
Today's Range
$67.77
$70.00
50-Day Range
$62.12
$76.87
52-Week Range
$61.94
$131.42
Volume
161,423 shs
Average Volume
193,920 shs
Market Capitalization
$759.25 million
P/E Ratio
6.36
Dividend Yield
9.47%
Price Target
$81.00

Medifast MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
16.2% Upside
$81.00 Price Target
Short Interest
Bearish
15.72% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
-3.90
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$414,632 Sold Last Quarter
Proj. Earnings Growth
-17.67%
From $9.34 to $7.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

Consumer Staples Sector

90th out of 134 stocks

Miscellaneous Food Preparations & Kindred Products Industry

3rd out of 4 stocks


MED stock logo

About Medifast Stock (NYSE:MED)

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.

MED Stock Price History

MED Stock News Headlines

Medifast, Inc. (MED) interactive stock chart – Yahoo Finance
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
5 Best High-Dividend Stocks to Buy Now
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Q3 2023 Medifast Inc Earnings Call
Medifast: Q3 Earnings Snapshot
Medifast Announces Third Quarter 2023 Financial Results
Preview: Medifast's Earnings
Medifast (MED) Targets New Customer Segments
Medifast: The Race To Weight-Loss Drugs Not Lost Yet
See More Headlines
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 11/7 Dividend
9/18/2023
Last Earnings
11/06/2023
Dividend Payable
11/07/2023
Today
12/05/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/20/2024

Industry, Sector and Symbol

Industry
Miscellaneous food preparations & kindred products
Sub-Industry
Personal Products
CUSIP
58470H10
Employees
874
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$81.00
High Stock Price Target
$82.00
Low Stock Price Target
$80.00
Potential Upside/Downside
+16.2%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$143.57 million
Pretax Margin
12.43%

Debt

Sales & Book Value

Annual Sales
$1.60 billion
Cash Flow
$16.29 per share
Book Value
$14.19 per share

Miscellaneous

Free Float
10,669,000
Market Cap
$759.25 million
Optionable
Optionable
Beta
1.23
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Daniel R. ChardMr. Daniel R. Chard (Age 58)
    Executive Chairman & CEO
    Comp: $1.94M
  • Mr. James P. Maloney CPA (Age 55)
    Chief Financial Officer
    Comp: $823.91k
  • Mr. Anthony E. Tyree (Age 58)
    Chief Business Operations Officer
    Comp: $655.86k
  • Mr. Jason L. Groves Esq. (Age 52)
    Executive VP, General Counsel & Corporate Secretary
    Comp: $669.51k
  • Mr. Nicholas M. Johnson (Age 43)
    Chief Field Operations Officer
    Comp: $696.4k
  • Mr. Jonathan Barrett MacKenzie (Age 51)
    VP of Finance & Chief Accounting Officer
  • Mr. Steven Zenker
    Vice President of Investor Relations
  • Ms. Claudia C. Greninger (Age 50)
    Chief Human Resources Officer














MED Stock Analysis - Frequently Asked Questions

Should I buy or sell Medifast stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Medifast in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" MED shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MED, but not buy additional shares or sell existing shares.
View MED analyst ratings
or view top-rated stocks.

What is Medifast's stock price target for 2024?

2 Wall Street research analysts have issued 1 year price targets for Medifast's stock. Their MED share price targets range from $80.00 to $82.00. On average, they predict the company's share price to reach $81.00 in the next year. This suggests a possible upside of 16.2% from the stock's current price.
View analysts price targets for MED
or view top-rated stocks among Wall Street analysts.

How have MED shares performed in 2023?

Medifast's stock was trading at $115.35 at the start of the year. Since then, MED stock has decreased by 39.6% and is now trading at $69.72.
View the best growth stocks for 2023 here
.

When is Medifast's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 20th 2024.
View our MED earnings forecast
.

How were Medifast's earnings last quarter?

Medifast, Inc. (NYSE:MED) posted its quarterly earnings results on Monday, November, 6th. The specialty retailer reported $2.12 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.02 by $1.10. The specialty retailer had revenue of $235.87 million for the quarter, compared to the consensus estimate of $232.10 million. Medifast had a net margin of 9.84% and a trailing twelve-month return on equity of 76.08%. The firm's revenue for the quarter was down 39.6% compared to the same quarter last year. During the same quarter last year, the business posted $3.32 earnings per share.

How often does Medifast pay dividends? What is the dividend yield for Medifast?

Medifast announced a quarterly dividend on Thursday, September 7th. Investors of record on Tuesday, September 19th will be given a dividend of $1.65 per share on Tuesday, November 7th. This represents a $6.60 annualized dividend and a yield of 9.47%. The ex-dividend date is Monday, September 18th.
Read our dividend analysis for MED
.

Is Medifast a good dividend stock?

Medifast (NYSE:MED) pays an annual dividend of $6.60 per share and currently has a dividend yield of 9.66%. MED has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 60.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on EPS estimates, MED will have a dividend payout ratio of 85.83% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for MED.

What guidance has Medifast issued on next quarter's earnings?

Medifast issued an update on its FY23 earnings guidance on Monday, November, 6th. The company provided earnings per share (EPS) guidance of $8.65-$9.55 for the period, compared to the consensus earnings per share estimate of $8.53. The company issued revenue guidance of $1.05-$1.07 billion, compared to the consensus revenue estimate of $1.09 billion.

What is Daniel Chard's approval rating as Medifast's CEO?

44 employees have rated Medifast Chief Executive Officer Daniel Chard on Glassdoor.com. Daniel Chard has an approval rating of 93% among the company's employees. This puts Daniel Chard in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Medifast own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Medifast investors own include NVIDIA (NVDA), Alibaba Group (BABA), AbbVie (ABBV), Home Depot (HD), Boeing (BA), Johnson & Johnson (JNJ), Intel (INTC), Cisco Systems (CSCO), AT&T (T) and Exxon Mobil (XOM).

Who are Medifast's major shareholders?

Medifast's stock is owned by many different institutional and retail investors. Top institutional investors include Bank of New York Mellon Corp (1.78%), Charles Schwab Investment Management Inc. (1.53%), JPMorgan Chase & Co. (1.40%), Jacobs Levy Equity Management Inc. (1.19%), Northern Trust Corp (1.16%) and AQR Capital Management LLC (1.12%). Insiders that own company stock include Andrea B Thomas, Constance J Hallquist, Constance J Hallquist, Daniel R Chard, Jeffrey J Brown, Jeffrey J Brown, Kevin G Byrnes and Scott Schlackman.
View institutional ownership trends
.

How do I buy shares of Medifast?

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:MED) was last updated on 12/5/2023 by MarketBeat.com Staff

My Account -